Ioanna Skampardoni,Ilya M. Nasrallah,Ahmed Abdulkadir,Junhao Wen,Randa Melhem,Elizabeth Mamourian,Guray Erus,Jimit Doshi,Ashish Singh,Zhijian Yang,Yuhan Cui,Gyujoon Hwang,Zheng Ren,Raymond Pomponio,Dhivya Srinivasan,Sindhuja Tirumalai Govindarajan,Paraskevi Parmpi,Katharina Wittfeld,Hans J. Grabe,Robin Bülow,Stefan Frenzel,Duygu Tosun,Murat Bilgel,Yang An,Daniel S. Marcus,Pamela LaMontagne,Susan R. Heckbert,Thomas R. Austin,Lenore J. Launer,Aristeidis Sotiras,Mark A. Espeland,Colin L. Masters,Paul Maruff,Jurgen Fripp,Sterling C. Johnson,John C. Morris,Marilyn S. Albert,R. Nick Bryan,Kristine Yaffe,Henry Völzke,Luigi Ferrucci,Tammie L.S. Benzinger,Ali Ezzati,Russell T. Shinohara,Yong Fan,Susan M. Resnick,Mohamad Habes,David Wolk,Haochang Shou,Konstantina Nikita,Christos Davatzikos

Abstract:Importance Brain aging elicits complex neuroanatomical changes influenced by multiple age-related pathologies. Understanding the heterogeneity of structural brain changes in aging may provide insights into preclinical stages of neurodegenerative diseases. Objective To derive subgroups with common patterns of variation in participants without diagnosed cognitive impairment (WODCI) in a data-driven manner and relate them to genetics, biomedical measures, and cognitive decline trajectories. Design, Setting, and Participants Data acquisition for this cohort study was performed from 1999 to 2020. Data consolidation and harmonization were conducted from July 2017 to July 2021. Age-specific subgroups of structural brain measures were modeled in 4 decade-long intervals spanning ages 45 to 85 years using a deep learning, semisupervised clustering method leveraging generative adversarial networks. Data were analyzed from July 2021 to February 2023 and were drawn from the Imaging-Based Coordinate System for Aging and Neurodegenerative Diseases (iSTAGING) international consortium. Individuals WODCI at baseline spanning ages 45 to 85 years were included, with greater than 50 000 data time points. Exposures Individuals WODCI at baseline scan. Main Outcomes and Measures Three subgroups, consistent across decades, were identified within the WODCI population. Associations with genetics, cardiovascular risk factors (CVRFs), amyloid β (Aβ), and future cognitive decline were assessed. Results In a sample of 27 402 individuals (mean [SD] age, 63.0 [8.3] years; 15 146 female [55%]) WODCI, 3 subgroups were identified in contrast with the reference group: a typical aging subgroup, A1, with a specific pattern of modest atrophy and white matter hyperintensity (WMH) load, and 2 accelerated aging subgroups, A2 and A3, with characteristics that were more distinct at age 65 years and older. A2 was associated with hypertension, WMH, and vascular disease–related genetic variants and was enriched for Aβ positivity (ages ≥65 years) and apolipoprotein E (APOE) ε4 carriers. A3 showed severe, widespread atrophy, moderate presence of CVRFs, and greater cognitive decline. Genetic variants associated with A1 were protective for WMH (rs7209235: mean [SD] B = −0.07 [0.01]; P value = 2.31 × 10 −9 ) and Alzheimer disease (rs72932727: mean [SD] B = 0.1 [0.02]; P value = 6.49 × 10 −9 ), whereas the converse was observed for A2 (rs7209235: mean [SD] B = 0.1 [0.01]; P value = 1.73 × 10 −15 and rs72932727: mean [SD] B = −0.09 [0.02]; P value = 4.05 × 10 −7 , respectively); variants in A3 were associated with regional atrophy (rs167684: mean [SD] B = 0.08 [0.01]; P value = 7.22 × 10 −12 ) and white matter integrity measures (rs1636250: mean [SD] B = 0.06 [0.01]; P value = 4.90 × 10 −7 ). Conclusions and Relevance The 3 subgroups showed distinct associations with CVRFs, genetics, and subsequent cognitive decline. These subgroups likely reflect multiple underlying neuropathologic processes and affect susceptibility to Alzheimer disease, paving pathways toward patient stratification at early asymptomatic stages and promoting precision medicine in clinical trials and health care.

The genetic architecture of multimodal human brain age

The Genetic Architecture of Biological Age in Nine Human Organ Systems

Partitioning Heritability Analyses Unveil the Genetic Architecture of Human Brain Multidimensional Functional Connectivity Patterns.

Nongenetic and Genetic Factors Associated with White Matter Brain Aging: Exposome-Wide and Genome-Wide Association Study

Genetic basis of neurocognitive decline and reduced white-matter integrity in normal human brain aging

The Interaction Effects of Age, APOE and Common Environmental Risk Factors on Human Brain Structure

Genomic loci influence patterns of structural covariance in the human brain

Discovery of High-Risk Clinical Factors That Accelerate Brain Aging in Adults: A Population-Based Machine Learning Study

Brain-age prediction: Systematic evaluation of site effects, and sample age range and size

Genomic Architecture of Human Neuroanatomical Diversity

Genetic Influence Underlying Brain Connectivity Phenotype: A Study on Two Age-Specific Cohorts

Brain age prediction across the human lifespan using multimodal MRI data

Gray matter volume drives the brain age gap in schizophrenia: a SHAP study

Older molecular brain age in severe mental illness

Human brain aging heterogeneity observed from multi-region omics data reveals a subtype closely related to Alzheimer’s disease

Brain aging patterns in a large and diverse cohort of 49,482 individuals

Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals

Voxelwise genome-wide association study (vGWAS)

MUTUAL INFORMATION OF NEUROIMAGES AND GENETIC VARIANTS TO STUDY THE DETERMINANTS OF BRAIN AGING

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

Mendelian randomization of genetically independent aging phenotypes identifies LPA and VCAM1 as biological targets for human aging